PEP-Therapy and Institut Curie granted approval from ANSM to start first-in-human clinical trial of PEP-010 ...
PEP-010 is a first-in-class therapeutic peptide based on PEP-Therapy’s innovative Cell Penetrating and Interfering Peptides (CP&IP) technology. These innovative molecules ...